2022 Q2 Form 10-Q Financial Statement

#000106299322016302 Filed on July 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $112.8K $132.0K $104.2K
YoY Change 37.54% -59.08% 162.74%
% of Gross Profit
Research & Development $39.52K $649.2K $12.26K
YoY Change 1394.18% 48025.28% 264.88%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $176.8K $781.2K $116.5K
YoY Change 105.64% 138.32% 170.72%
Operating Profit -$176.8K -$781.8K -$117.0K
YoY Change 105.64% 138.5%
Interest Expense $2.211K -$7.310K $280.00
YoY Change 675.79% -2321.88% -98.21%
% of Operating Profit
Other Income/Expense, Net $23.80K $50.00K $0.00
YoY Change 17.97% 602.05% -100.0%
Pretax Income $3.636M -$738.5K -$116.2K
YoY Change -4092.13% 150.15% -152.21%
Income Tax
% Of Pretax Income
Net Earnings $3.636M -$738.5K -$116.2K
YoY Change -4092.3% 150.15% -152.21%
Net Earnings / Revenue
Basic Earnings Per Share $0.02 $0.00 $0.00
Diluted Earnings Per Share $0.02 -$4.859K -$821.10
COMMON SHARES
Basic Shares Outstanding 155.1M shares 152.0M shares 141.5M shares
Diluted Shares Outstanding 155.1M shares 152.0M shares 141.5M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.797M $131.2K $375.9K
YoY Change 1015.6% -71.44% 26.68%
Cash & Equivalents $1.034M $131.2K $360.4K
Short-Term Investments $2.763M $0.00 $15.44K
Other Short-Term Assets $111.5K $137.3K $30.16K
YoY Change 26.59% 155.35% 33.81%
Inventory
Prepaid Expenses $111.5K
Receivables $2.740K $580.00 $6.070K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.911M $269.0K $412.1K
YoY Change 804.54% -47.68% 28.15%
LONG-TERM ASSETS
Property, Plant & Equipment $10.50K $10.50K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.50K $10.50K $0.00
YoY Change -84.78% -84.78% -100.0%
TOTAL ASSETS
Total Short-Term Assets $3.911M $269.0K $412.1K
Total Long-Term Assets $10.50K $10.50K $0.00
Total Assets $3.922M $279.5K $412.1K
YoY Change 682.16% -52.07% 28.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $286.6K $274.7K $289.1K
YoY Change 1.35% 0.08% -1.31%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $366.8K $360.1K $379.7K
YoY Change -12.82% -17.11% -20.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $366.8K $360.1K $379.7K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $366.8K $360.1K $379.7K
YoY Change -12.82% -17.11% -20.31%
SHAREHOLDERS EQUITY
Retained Earnings -$11.89M
YoY Change
Common Stock $155.1K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.555M -$80.60K $32.39K
YoY Change
Total Liabilities & Shareholders Equity $3.922M $279.5K $412.1K
YoY Change 682.16% -52.07% 28.16%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $3.636M -$738.5K -$116.2K
YoY Change -4092.3% 150.15% -152.21%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$147.0K -$278.8K -$125.3K
YoY Change 12.75% 118.62% 210.64%
INVESTING ACTIVITIES
Capital Expenditures -$10.50K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.061M $49.56K $0.00
YoY Change 4098.34% 66.09% -100.0%
Cash From Investing Activities $1.050M $49.56K $0.00
YoY Change 4056.77% 66.09% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 131.4K
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -147.0K -278.8K -125.3K
Cash From Investing Activities 1.050M 49.56K 0.000
Cash From Financing Activities 0.000 0.000 131.4K
Net Change In Cash 903.0K -229.2K 6.140K
YoY Change -1091.36% -244.2% -97.1%
FREE CASH FLOW
Cash From Operating Activities -$147.0K -$278.8K -$125.3K
Capital Expenditures -$10.50K
Free Cash Flow -$136.5K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 usd
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
136563844 shares
enrt Shares Received For Mineral Property Sale
SharesReceivedForMineralPropertySale
3432382 usd
enrt Shares Received For Mineral Property Sale
SharesReceivedForMineralPropertySale
0 usd
enrt Fair Value Of Shares Issued For Hydrogen Technology
FairValueOfSharesIssuedForHydrogenTechnology
100400 usd
enrt Fair Value Of Shares Issued For Hydrogen Technology
FairValueOfSharesIssuedForHydrogenTechnology
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155116088 shares
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3635630 usd
CY2022Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
8974 usd
CY2021Q2 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;text-indent:-35pt;margin-left:35pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>b)</strong></span></span><span style="padding-left:25pt"> </span><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Accounting Estimates</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions.</span></span></p> </div>
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y4M24D
CY2022Q2 us-gaap Other Commitment
OtherCommitment
9500 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
45528 usd
CY2020Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15450 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
222603 usd
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139211700 shares
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
9005 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000 usd
CY2021Q4 enrt Stock Options Granted On September One
StockOptionsGrantedOnSeptemberOne
23056 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116219 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32386 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
2211 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-80601 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
285 usd
CY2021Q2 enrt Income From Sale Of Mineral Property
IncomeFromSaleOfMineralProperty
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
55877 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
10049 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
2598 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
7855 usd
CY2021Q2 us-gaap Lease Cost
LeaseCost
2639 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
9005 usd
us-gaap Share Based Compensation
ShareBasedCompensation
297691 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-85986 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q2 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
30984 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-7641 usd
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
53488 usd
CY2022Q2 enrt Income From Sale Of Mineral Property
IncomeFromSaleOfMineralProperty
4482382 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
155116088 shares
enrt Shares Issued For Battery Management Technology
SharesIssuedForBatteryManagementTechnology
450000 usd
enrt Net Proceeds From Subscriptions Received
NetProceedsFromSubscriptionsReceived
180000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-551009 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-298188 usd
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10076776 shares
CY2021Q3 us-gaap Share Price
SharePrice
0.0629
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3626776 shares
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
48589 usd
CY2022Q2 us-gaap Other Commitment
OtherCommitment
3500 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
113388 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
155116088 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
139211700 shares

Files In Submission

Name View Source Status
0001062993-22-016302-index-headers.html Edgar Link pending
0001062993-22-016302-index.html Edgar Link pending
0001062993-22-016302.txt Edgar Link pending
0001062993-22-016302-xbrl.zip Edgar Link pending
enrt-20220531.xsd Edgar Link pending
enrt-20220531_cal.xml Edgar Link unprocessable
enrt-20220531_def.xml Edgar Link unprocessable
enrt-20220531_lab.xml Edgar Link unprocessable
enrt-20220531_pre.xml Edgar Link unprocessable
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
form10qxz002.jpg Edgar Link pending
form10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending